Literature DB >> 30648486

Metabolic Obesity Phenotypes and Thyroid Cancer Risk: A Cohort Study.

Hyemi Kwon1, Yoosoo Chang2,3,4, Ara Cho2, Jiin Ahn2, Se Eun Park1, Cheol-Young Park1, Won-Young Lee1, Ki-Won Oh1, Sung-Woo Park1, Hocheol Shin2,5, Seungho Ryu2,3,4, Eun-Jung Rhee1.   

Abstract

BACKGROUND: No cohort studies have evaluated the effect of obesity on the incidence of thyroid cancer according to metabolic health status. Therefore, this study examined the association of body mass index (BMI) and metabolic health status with thyroid cancer risk.
METHODS: A cohort study was performed involving 255,051 metabolically healthy (MH) and metabolically unhealthy (MUH) adults free of thyroid cancer at baseline who were followed for a median of 5.3 years. A parametric proportional hazard model was used to estimate the adjusted hazard ratio (aHR) and confidence interval (CI).
RESULTS: During 1,402,426.3 person-years of follow-up, 2927 incident thyroid cancers were identified. Among men, the multivariable aHR for thyroid cancer comparing obesity, defined as a BMI ≥25 kg/m2, with a BMI of 18.5-22.9 kg/m2 was 1.47 [CI 1.12-1.93] in MH individuals, whereas the corresponding HR in MUH individuals was 1.26 [CI 1.03-1.53]. Among women, the corresponding HR in MH individuals was 1.05 [CI 0.80-1.36], whereas the corresponding HR in MUH individuals was 1.43 [CI 1.22-1.69]. Increasing quartiles of waist circumference were positively associated with risk of thyroid cancer in MUH men and women (p for trend <0.005) but not in MH individuals.
CONCLUSIONS: In both MH and MUH men, obesity was associated with an increased risk of incident thyroid cancer, indicating excessive adiposity per se as an independent risk factor for thyroid cancer. Conversely, women with MUH obesity but not MH obesity were found to have an increased risk of thyroid cancer, indicating that obesity with accompanying metabolic abnormalities may affect thyroid cancer risk in women.

Entities:  

Keywords:  body mass index; metabolic health; obesity; risk factors; thyroid cancer

Mesh:

Year:  2019        PMID: 30648486     DOI: 10.1089/thy.2018.0327

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  10 in total

1.  Weight Loss and Changes in Adipose Tissue and Skeletal Muscle Volume after Laparoscopic Sleeve Gastrectomy and Roux-en-Y Gastric Bypass: a Prospective Study with 12-Month Follow-Up.

Authors:  Hannes Götz Kenngott; Felix Nickel; Philipp Anthony Wise; Felix Wagner; Adrian Theophil Billeter; Johanna Nattenmüller; Diana Nabers; Klaus Maier-Hein; Hans-Ulrich Kauczor; Lars Fischer; Beat Peter Müller-Stich
Journal:  Obes Surg       Date:  2019-12       Impact factor: 4.129

2.  Clinicopathological features and prognosis of papillary thyroid cancer patients with type 2 diabetes mellitus.

Authors:  Ping Shi; Lan Zhang; Yan Liu; Fei Yang; Kai Fu; Ruicong Li; Huijing Shi; Yanzhao Wu
Journal:  Gland Surg       Date:  2022-02

3.  Alterations of Gut Microbiome and Metabolite Profiles Associated With Anabatic Lipid Dysmetabolism in Thyroid Cancer.

Authors:  Ganghua Lu; Xiaqing Yu; Wen Jiang; Qiong Luo; Junyu Tong; Suyun Fan; Li Chai; Dingwei Gao; Tingting Qiao; Ru Wang; Chengwen Deng; Zhongwei Lv; Dan Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-03       Impact factor: 6.055

4.  Association between different obesity phenotypes and hypothyroidism: a study based on a longitudinal health management cohort.

Authors:  Yupeng Wang; Haiyan Lin; Qihang Li; Liying Guan; Meng Zhao; Fang Zhong; Jing Liu; Zhongshang Yuan; Honglin Guo; Yongfeng Song; Ling Gao; Jiajun Zhao
Journal:  Endocrine       Date:  2021-04-05       Impact factor: 3.633

5.  Epidemiologic, Clinical, Ultrasonographic, and Cytological Features of Thyroid Nodules in Predicting Malignancy Risk: A Retrospective Study of 442 French Afro-Caribbean Patients.

Authors:  Johan Joseph-Auguste; Lucien Lin; Magalie Demar; Olivier Duffas; Vincent Molinie; Caroline Sulpicy; Marie-Josée Dorival; Olivier Luxembourger; Nadia Sabbah
Journal:  Int J Endocrinol       Date:  2020-03-31       Impact factor: 3.257

6.  Point of Care Measurement of Body Mass Index and Thyroid Nodule Malignancy Risk Assessment.

Authors:  Sara Ahmadi; Theodora Pappa; Alex S Kang; Alexandra K Coleman; Iñigo Landa; Ellen Marqusee; Matthew Kim; Trevor E Angell; Erik K Alexander
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-11       Impact factor: 5.555

Review 7.  The association of obesity with thyroid carcinoma risk.

Authors:  Xiao-Ni Ma; Cheng-Xu Ma; Li-Jie Hou; Song-Bo Fu
Journal:  Cancer Med       Date:  2022-01-15       Impact factor: 4.452

8.  The Association Between Metabolic Status and Risk of Cancer Among Patients With Obesity: Metabolically Healthy Obesity vs. Metabolically Unhealthy Obesity.

Authors:  Xiaonan Zheng; Ruilin Peng; Hang Xu; Tianhai Lin; Shi Qiu; Qiang Wei; Lu Yang; Jianzhong Ai
Journal:  Front Nutr       Date:  2022-02-25

9.  Repeated Low High-Density Lipoprotein Cholesterol and the Risk of Thyroid Cancer: A Nationwide Population- Based Study in Korea.

Authors:  Jinyoung Kim; Mee Kyoung Kim; Ki-Hyun Baek; Ki-Ho Song; Kyungdo Han; Hyuk-Sang Kwon
Journal:  Endocrinol Metab (Seoul)       Date:  2022-04-06

10.  Liver X Receptor β Related to Tumor Progression and Ribosome Gene Expression in Papillary Thyroid Cancer.

Authors:  Seonhyang Jeong; In-Kyu Kim; Hyunji Kim; Moon Jung Choi; Jandee Lee; Young Suk Jo
Journal:  Endocrinol Metab (Seoul)       Date:  2020-08-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.